Susquehanna International Group
PEAR

Susquehanna International Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Susquehanna International Group’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-106,100
Closed -$163K – 14536
2022
Q2 		$163K Buy
+106,100
New +$415K ﹤0.01% 10923

Susquehanna International Group's PEAR Position: Q2 2023 in Review

Susquehanna International Group sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 30,170 shares — an estimated $7.69K sold.

Susquehanna International Group first reported a position in PEAR in Q3 2021 and held it in 5 quarters. The position peaked at $767K in Q3 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • Susquehanna International Group reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 30,170 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $7.69K.
  • Susquehanna International Group first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2021 and held it in 5 quarters.
  • Susquehanna International Group's Pear Therapeutics, Inc. Class A Common Stock position peaked at $767K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.